Capricor Therapeutics Inc (CAPR)

05:30 AM

Historical volatility pattern of Capricor Therapeutics Inc. visualizedM&A Rumor & AI Driven Price Forecasts - newser.com

05:30 AM

04:43 AM

Capricor Therapeutics (NASDAQ:CAPR) Stock Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

04:43 AM

03:07 AM

How Capricor Therapeutics Inc. stock reacts to job market dataQuarterly Investment Review & Safe Entry Momentum Tips - newser.com

03:07 AM

02:30 AM

Can trapped investors hope for a rebound in Capricor Therapeutics Inc.Stock Surge & Breakout Confirmation Trade Signals - newser.com

02:30 AM

Oct 13, 2025

How analysts rate Capricor Therapeutics Inc. stock todayJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com

Oct 13, 2025

Oct 13, 2025

Heatmap analysis for Capricor Therapeutics Inc. and competitors2025 Price Momentum & Community Verified Trade Alerts - newser.com

Oct 13, 2025

Oct 13, 2025

Capricor Therapeutics : Investor PresentationOctober 2025 - MarketScreener

Oct 13, 2025

Oct 13, 2025

What institutional flow reveals about Capricor Therapeutics Inc.2025 Price Targets & Community Consensus Picks - newser.com

Oct 13, 2025

Oct 12, 2025

Capricor Therapeutics, Inc. (CAPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Oct 12, 2025

Oct 10, 2025

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Exploring a 170% Upside Potential in Biotechnology - DirectorsTalk Interviews

Oct 10, 2025

Oct 10, 2025

Is a relief rally coming for Capricor Therapeutics Inc. holdersWeekly Risk Summary & Daily Profit Focused Screening - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Capricor Therapeutics (NASDAQ:CAPR) - MarketBeat

Oct 09, 2025

Oct 09, 2025

Capricor Therapeutics, Inc. (CAPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Oct 09, 2025

Oct 09, 2025

Is FDA Embrace of HOPE-3 Data Shaping the Investment Thesis for Capricor Therapeutics (CAPR)? - Sahm

Oct 09, 2025

Oct 09, 2025

Will Capricor Therapeutics Inc. (4LN2) stock outperform energy sector in 2025Weekly Loss Report & Community Driven Trade Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Oct 08, 2025

Oct 07, 2025

Capricor Therapeutics Inc Stock Analysis and ForecastMomentum Stock Picks & Minimal Investment Capital Gains - earlytimes.in

Oct 07, 2025

Oct 07, 2025

What drives Capricor Therapeutics Inc 4LN2 stock priceMarket Correction Analysis & Affordable Market Insights - earlytimes.in

Oct 07, 2025

Oct 06, 2025

Will Capricor Therapeutics Inc. stock see PE expansionInsider Buying & Free Verified High Yield Trade Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Volume spikes in Capricor Therapeutics Inc. stock – what they meanWeekly Market Report & Daily Technical Forecast Reports - newser.com

Oct 06, 2025

Oct 06, 2025

Will Capricor Therapeutics Inc. (4LN2) stock profit from AI boom2025 Market Overview & Growth Focused Investment Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Is Capricor Therapeutics Inc. stock resilient to inflationJuly 2025 Technicals & Community Supported Trade Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

New Drug for Duchenne Muscular Dystrophy Nears Potential Approval - streetwisereports.com

Oct 06, 2025

Oct 05, 2025

Capricor Therapeutics Inc. recovery potential after sell off2025 Sector Review & Safe Entry Zone Tips - newser.com

Oct 05, 2025

Oct 05, 2025

Published on: 2025-10-05 04:39:29 - newser.com

Oct 05, 2025

Oct 05, 2025

Is Capricor Therapeutics Inc. (4LN2) stock a good hedge against inflation2025 Top Gainers & Community Verified Swing Trade Signals - newser.com

Oct 05, 2025

Oct 04, 2025

User - FinancialContent

Oct 04, 2025

Oct 03, 2025

Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation - GlobeNewswire

Oct 03, 2025

Oct 03, 2025

There's Reason For Concern Over Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Massive 26% Price Jump - 富途牛牛

Oct 03, 2025

Oct 03, 2025

Head to Head Review: Baxter International (NYSE:BAX) and Capricor Therapeutics (NASDAQ:CAPR) - Defense World

Oct 03, 2025

Oct 02, 2025

Largest borrow rate increases among liquid names - TipRanks

Oct 02, 2025

Oct 01, 2025

Biotech Secures FDA Alignment on Late-Stage Duchenne Therapy - streetwisereports.com

Oct 01, 2025

Oct 01, 2025

Biotech Battles FDA, Target Price Shows Potential 90% Gains - streetwisereports.com

Oct 01, 2025

Sep 30, 2025

Hope On The Horizon As Capricor's HOPE-3 Trial For Duchenne Muscular Dystrophy Nears Data Readout - RTTNews

Sep 30, 2025

Sep 30, 2025

Is ICICI Prudential Asset Management Co Ltd Stock a Strong Buy According to Wall StreetGlobal Trade Effects & Free Stock Trading Workshops - earlytimes.in

Sep 30, 2025